Among all, N-terminal residue Arginine59 within the DNA binding domain was changed to Leucine (R59L), a change similar to a conserved mutation in the mammalian gcmb gene carried by hypoparathyroidism patients (Fig. 1a)19, 32, 33, 34. This evidence concerns the gene GCM2 and hypoparathyroidism.